Select Medical Holdings Corporation (NYSE:SEM) Given Average Rating of “Moderate Buy” by Analysts

Shares of Select Medical Holdings Corporation (NYSE:SEM) have been given a consensus rating of “Moderate Buy” by the six research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have given a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $17.80.

SEM has been the topic of several analyst reports. Weiss Ratings reiterated a “sell (d+)” rating on shares of Select Medical in a report on Wednesday, January 21st. Mizuho set a $17.00 price target on Select Medical in a research note on Monday, November 3rd. Benchmark reissued a “buy” rating on shares of Select Medical in a research note on Monday, October 27th. Finally, Wall Street Zen raised shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th.

Select Medical Trading Down 0.1%

Shares of SEM opened at $15.67 on Tuesday. Select Medical has a fifty-two week low of $11.65 and a fifty-two week high of $19.54. The firm has a market cap of $1.94 billion, a price-to-earnings ratio of 18.22, a PEG ratio of 0.55 and a beta of 1.25. The firm has a 50 day moving average price of $15.13 and a 200-day moving average price of $13.92. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.09 and a current ratio of 1.09.

Institutional Trading of Select Medical

Institutional investors have recently modified their holdings of the company. 8 Knots Management LLC purchased a new position in shares of Select Medical in the 2nd quarter valued at approximately $26,568,000. Millennium Management LLC lifted its position in Select Medical by 407.9% during the third quarter. Millennium Management LLC now owns 1,590,339 shares of the health services provider’s stock valued at $20,420,000 after buying an additional 1,277,233 shares during the period. Western Standard LLC bought a new stake in shares of Select Medical during the 3rd quarter valued at $13,551,000. Qube Research & Technologies Ltd purchased a new stake in shares of Select Medical in the 3rd quarter worth about $7,401,000. Finally, Woodline Partners LP bought a new position in shares of Select Medical in the 3rd quarter worth about $7,159,000. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.